- Journalists Distill News on Ebola, Licensing Midwives, and California’s Budget
- Justice Department charges 15 for $90M+ in alleged healthcare fraud, expands strike force
- UnitedHealth’s PBM names CFO
- Tennessee becomes 2nd state to ban PBMs from owning pharmacies
- Trump Bought Stock in Eli Lilly as His Policies Gave the Drugmaker a Big Boost, Documents Show
- 40% lower physician distress, 245% more violence reporting: Workforce retention strategies gaining traction
- 15 new behavioral health study findings to know
- APRN charged in $1.35M Medicare fraud scheme
- Florida woman faces charges of practicing unlicensed dentistry
- GI of the Rockies launches AI-powered care program
- Deputy injured in Indiana hospital shooting
- Legacy Health-backed insurer PacificSource to exit ACA market, pull out of Montana entirely
- Expanded federal scrutiny reshapes how hospitals govern risk, compliance
- The instability compounding the anesthesiologist shortage
- ADA proposes standards on dental cartridges, water quality
- The unraveling of prior authorization: 5 things to know
- The hospital bad debt and charity care crisis: 20 things to know
- As AI identifies more at-risk patients, health systems face a capacity challenge
- 5 GI power players
- 4 dental insurance updates to know
- Federal appeals court overturns EPA fluoride ruling: 5 notes
- What payers don’t understand about ASC spine surgery
- 3 men sentenced for $6.9M orthotic DME fraud scheme
- What will outpatient cardiology look like in 10 years?
- 15 leadership moves across 4 specialties
- Dental Medicaid disenrollment could cause $86M in added costs
- Park Dental opens Minnesota practice
- AI is about to break healthcare’s scarcity model — if we let it
- The most underrated threat in digital health
- Tennessee orthodontic practice opens 2 locations
- Justice Department charges autism care providers in $46.6M fraud case
- 14.2% of Medicaid patients received mental health ED follow-up: 4 notes
- Acting NIAID Chief Steps Down Amid Ebola, Hantavirus Concerns
- Leaders sound off on overrated ASC trends
- Dental hygienist employment reaches 222,000: State-by-state breakdown
- Vitana Pediatric & Orthodontic Partners adds 1st Maryland practice
- 10 highest-paying states for dental hygienists in 2026
- US overdose deaths decline for 3rd straight year: What it means for healthcare
- Sunscreen Confusion Puts More Americans At Risk For Melanoma
- ACAP warns final ACA rule adds further uncertainty to a market in flux
- AbbVie plots 85 summer layoffs tied to Allergan unit in California
- Quorum Health transitioning to nonprofit for financial pickup
- Women's Health Capitol Hill Day: Advocates lobby to advance budget priorities
- Europe's CHMP gives thumbs up to AZ's breast cancer drug after thumbs down from FDA adcomm
- Novartis, AbbVie plan summer layoffs on opposite coasts
- AstraZeneca, Daiichi beat Gilead to first-line TNBC with FDA nod for Datroway
- Industry Voices—From claims to compassion: Reclaiming patient advocacy in revenue cycle
- 1 In 10 U.S. Surgeons Quit Practice, Study Warns Of Shortage
- Video Game Can Detect Depression In Minutes, Study Says
- Quitting Smoking Might Lower Your Dementia Risk
- Severe Asthma Often Comes With Other Serious Health Problems
- AbbVie, GSK race up patient reputation leaderboard in the UK
- Efforts To Understand The Nation's Drugged Driving Problem Stall Under Trump
- Trump’s $50B Rural Health Bet Meets a Healthcare Desert in North Carolina
- 3 Medical Routines That Older People May Not Need
- Fierce Pharma Asia—Merck-Kelun ADC’s triple wins; Tools in China licensing deals; Takeda’s $885M antitrust loss
- Tyra creates awareness day with patient advocates to shine light on a rare cancer
- Machine learning-guided lifestyle plans reduce depression symptoms: 3 study notes
- Innovaccer picks up CaduceusHealth to offer end-to-end revenue cycle management
- Acadia psychiatric hospital faces abuse lawsuits
- Massachusetts behavioral health clinics to pay $1.4M to settle fraud allegations
- From 50 days to 7: How 1 system cut behavioral health intake wait times
- Hospitals allege contracted CVS Health subsidiaries pocketed their 340B savings
- Northwell hospital launches in-home behavioral health services
- RFK Jr. Fires Two Leaders Of Major U.S. Health Task Force
- Ksana Health awarded $17.9M to build behavioral health foundation model
- Lilly accuses church-linked pharmacies, wholesalers and more of running $200M+ rebate fraud scheme
- Study: Brokers increasingly recommending ICHRA to employers
- ASCO: Merck, Kelun's sac-TMT ADC combo beats Keytruda by 65% on progression in first-line lung cancer
- Common Food Preservatives Linked to Major Heart Problems
- Health Tech Weekly Rundown: Prime Healthcare expands virtual sitting tech; CVS Health studies seniors' digital health needs
- Amgen's Tavneos, facing liver injury scrutiny, gets label update in Japan as patient starts resume
- Gilead pledges 400K AmBisome doses to fight visceral leishmaniasis in expanded WHO collab
- With Voxzogo under pressure, BioMarin touts trial win in label expansion bid
- Migraine With Aura Linked To Middle-Age Stroke Risk
- Nicotine Vapes Triple Smokers' Odds Of Quitting Tobacco
- Fatty Liver Disease Increases Heart Attack Risk, Study Says
- Religious Anti-Abortion Center Finds Opportunity In Town Without OB-GYNs
- CPAP Insurance Rules Too Stringent, Deny Device Coverage To Sleep Apnea Patients Who Would Benefit
- ICE Arrests Are Separating Families. Here’s How To Plan Ahead.
- Colorado Charts Its Own Course on Vaccines Amid Federal Pullback
- OpenEvidence launches hands-free voice AI feature, expands hospital footprint with Cedars-Sinai tie-up
- Inside agency view: Ogilvy Health on AI’s ‘light speed,’ nano influencers and the rise of Ria
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- The failure of the ‘usual suspects’ approach to life science recruitment
- The failure of the ‘usual suspects’ approach to life science recruitment
- Kennedy dismisses leaders of US Preventive Services Task Force
- Statement on Novel Exchange-Traded Funds (ETFs)
- CMS proposes rule aimed at limiting Medicaid state-directed payments
- WTW: Employers aiming to bulk up AI use for health and benefits
- Freestanding EDs, urgent care acquisition opportunities abound for HCA Healthcare
- Value, Focus, and the Future of MedTech: M&A and Divestitures are Rewriting the Strategic Playbook.
- Value, Focus, and the Future of MedTech: M&A and Divestitures are Rewriting the Strategic Playbook.
- Rollback of PFAS Drinking Water Standards Raises Safety Fears
- 'Missed risk': Women's Heart Health Summit explores gaps in research, treatment
- House and Senate Democrats move to overturn CMS’ WISeR AI prior auth pilot
- Designing an agentic, future‑ready tech roadmap for emerging pharma
- Judi Health taps Clear for its identity verification tech
- Canvas Medical unveils Canvas Studio, a customizable EMR workflow tool for clinicians
- The Boston Children’s Experience: Hidden ICU Risk and AI-Driven De-escalation
- The Boston Children’s Experience: Hidden ICU Risk and AI-Driven De-escalation
- Artivion Completes Endospan Acquisition, Expands Aortic Arch Portfolio With FDA-Approved NEXUS System
- Artivion Completes Endospan Acquisition, Expands Aortic Arch Portfolio With FDA-Approved NEXUS System
- Your Handwriting Could Be a Window Into Your Aging Brain
- Democratic senators share plans for Medicare home care benefit, long-term care reform
- GHO Capital, CBC Group plan to merge, forming $21B healthcare investment firm
- Ipsen details growing pains as teens transition to adult care
- Lilly, AbbVie, J&J, AZ lead an uptick in Big Pharma Q1 growth, with Novo again bringing up the rear
- MetroHealth partners with Artisight on smart hospital platform rollout
- How Do Caffeine, Alcohol, Weed, Nicotine Affect MS Symptoms?
- Once-A-Day Pill Effective In Treating Sleep Apnea Without CPAP, Clinical Trial Says
- Teens Turning To Creatine, Not Steroids, For 'Looksmaxxing'
- BMS taps Anthropic’s Claude for enterprise-wide AI adoption to speed R&D, global workflows
- Gilead inks another deal with Korean API manufacturer Yuhan, this time worth $140M
- Childhood Trauma Tied to Higher Obesity Risk, But One Caring Adult Can Make A Difference
- Eroding ACA Enrollment Portends Higher Insurance Rates
- Amgen, bidding adieu to CFO, lures Galderma exec with hefty $12.4M bonus
- Watch: The Tug-of-War Over Taxpayer Dollars
- Religious Anti-Abortion Center Finds Opportunity in Town Without OB-GYNs
- CG Life appoints Collette Douaihy as chief creative officer as C-suite buildout continues
- Tarsus taps John Cena for its latest Demodex blepharitis campaign
- Statement on Proposing Registered Offering Reform and Enhancement of Emerging Growth Company Accommodations and Simplification of Filer Status for Reporting Companies
- American Aid Worker Tests Positive for Ebola After DRC Exposure
- Listen to the Latest ‘KFF Health News Minute’
- Headache Medicine: Statement on Proposing Releases for Registered Offering Reform and Enhancement of Emerging Growth Company Accommodations and Simplification of Filer Status for Reporting Companies
- More Kids Seeking Anxiety Help at Routine Doctor Visits, Study Finds
- Statement on Proposing Releases for Enhancement of Emerging Growth Company Accommodations and Simplification of Filer Status for Reporting Companies, and Registered Offering Reform
- Global MedTech Contract Manufactures Finalize Merger
- Global MedTech Contract Manufactures Finalize Merger
- Carl Zeiss Meditec Plans Up to 1,000 Job Cuts Amid Restructuring Effort
- Carl Zeiss Meditec Plans Up to 1,000 Job Cuts Amid Restructuring Effort
- Signatera CDx Gets FDA Nod as Companion Diagnostic for Muscle-Invasive Bladder Cancer
- Signatera CDx Gets FDA Nod as Companion Diagnostic for Muscle-Invasive Bladder Cancer
- Boston Scientific announces strategic investment in MiRus LLC
- Boston Scientific announces strategic investment in MiRus LLC
- Weed/Opioid Combo Doesn't Help Knee Arthritis Pain
- Losing A Parent Can Dent An Adult's Earning Power
- Ticks Can Creepy-Crawl Your House For Weeks Before Dying, Study Shows
- Kids Keep Getting Stuck in Hospitals, Even After Being Cleared For Discharge
- Short, Intense Radiation Therapy Safe For Prostate Cancer Patients
- Efforts To Understand the Nation’s Drugged Driving Problem Stall Under Trump
- Somewhere Between Cacophony and Euphony
- Ebola Outbreaks in Africa Trigger Global Health Emergency, U.S. Travel Warnings
- Rapid Weight Loss Beats Slow and Steady in New Clinical Trial
- Medtronic Bets on Cardiovascular Realignment Amid Stock Pressure and Facility Closures
- Medtronic Bets on Cardiovascular Realignment Amid Stock Pressure and Facility Closures
- Smog Linked To Lewy Body Dementia Risk, Major Study Finds
- NYC Mold Removal Program Cut Asthma ER Cases By A Quarter, Study Says
- Pregnancy Safe For Women With Myasthenia Gravis, Study Concludes
Jay Bhattacharya proposes limiting the future authorities of the public health establishment to prevent the absurdities and deaths of the last three years:
https://brownstone.org/articles/power-of-public-health-agencies-must-be-curbed/
The Power of Public Health Agencies Must Be Curbed
BY Jayanta Bhattacharya - May 19, 2023Over the past three years, the public has seen first-hand the tremendous power the public health establishment wields. Using emergency power that most people never realized an American government possessed, public health violated Americans’ most fundamental civil rights in the name of infection control.
We endured three years of useless and divisive policies, including lockdowns, church and business closures, Zoom schools, mask mandates, and vaccine mandates and discrimination. Now that the WHO has declared the end of the covid pandemic and CDC Director Rochelle Walensky has announced her resignation, it is time for states to take action to limit the power of public health so that a repeat never happens again.
Contrary to what you hear these days from those making poor decisions throughout the pandemic, many of the errors were not honest mistakes. Public health embraced positions at odds with the scientific evidence throughout the pandemic, for instance, by pretending that immunity after COVID recovery does not exist, and by overstating the ability of the vaccine to stop COVID infection and transmission. Despite many getting vaccinated, COVID spread and people died anyway, with tremendous collateral harm—both economic and in terms of public health—deriving from the favored policies of our public health institutions.
It is time to adopt laws to limit the powers of public health.
Because public health used two tactics to enact its will on the public, the restrictions on public health power must address both. First, it promulgated direct mandates and binding “guidances” that were enforced by the police power of the government. For example, in the spring of 2020, the police arrested a paddle boarder for the crime of enjoying an empty Southern California beach on a sunny day.
Second, public health authorities induced fear by exaggerating the mortality risk of covid infection. This tactic also worked: Surveys show that people vastly overestimate the risk of dying if infected. It’s no coincidence that large corporations, small businesses, and regular people “voluntarily” enforced public health guidance even beyond the letter of the recommendations. The “guidance” issued by the CDC and the WHO, which was not subject to prior public comment or cost-benefit analysis, took on the force of law.
Legislation is crucial to combatting this grave abuse of the public, especially given how public health’s tyrannical playbook is now the accepted norm among public health leaders at the national and international levels. The WHO’s revision of its International Health Regulations and new pandemic treaty push member states to increase the power of centralized public health authorities during health emergencies. The recently released “Lessons from the Covid War” by the Covid Crisis Group excuses the sins of public health by blaming its failures on insufficient funding for public health priorities and inadequate power. As things stand, in the next pandemic, the lockdowns will recur.
The good news is that some states are adopting laws to limit public health authorities’ ability to impose draconian emergency interventions without proper justification. One example is SB 252, just passed by the Florida legislature. The bill prohibits both government and private businesses from discriminating against people based on COVID vaccination, prohibits involuntary COVID testing, and limits the deployment of mask requirements (except for healthcare providers). Most importantly, the bill prohibits government entities and educational institutions from treating WHO and CDC guidance as if their pronouncements were law—unless the state explicitly adopts it.
While some of these protections, like the ban on COVID vaccine mandates, were already in place in Florida, these restrictions were due to expire soon. SB 252 will permanently restore the proper place of public health as an institution that issues recommendations rooted in science rather than quasi-legal “guidance”—a wise policy given that businesses and educational institutions cannot reliably evaluate the science underlying public health diktats.
But the bill doesn’t just protect our rights as citizens; it’s good for public health, too.
Before the pandemic, I naively thought that a commitment to basic ethical principles constrained public health actions, and would therefore have opposed the Florida bill banning discrimination based on vaccination status. Now, I see the bill’s wisdom. I have learned not to trust public health authorities with expansive power anymore.
And I am of course not alone. Public trust in public health has cratered due to overzealous enforcement of its guidance far past diminishing returns. It can only recover once public health authorities face the same checks and balances as other parts of government.
In theory, there is a risk to restricting public health action: It will make coordinated nationwide action more difficult in the next pandemic. What if next time, we have a disease outbreak that requires every part of the country to shut down everywhere, all at once, for a long time?
It’s exceedingly unlikely that such a situation would occur, though it’s easy to articulate in science fiction novels. It’s certainly never happened in the country’s history.
It’s not that there won’t be another pandemic: There will be. But a uniform national response will never be the right response, for the simple reason that the US is such a large, geographically and culturally diverse country. Early spread will happen in hotspots, while others will not be affected until later.
Responses that account for local situations will be needed, and bills like SB 252 make that more likely.
Now that states are moving to restrict public health powers, public health authorities face a choice that will decide whether the public will ever trust public health again. They can fight a partisan political battle against these laws, and the collapse of public trust in public health will continue apace. Or they can gracefully accept limits to their power in light of their pandemic failures.
If public health opts for the latter, rejects authoritarian power, and restores its commitment to basic ethical principles, it may regain the public’s trust so that it can creatively address the challenges to health that the American people now face.
Jay Bhattacharya is a physician, epidemiologist and health economist. He is Professor at Stanford Medical School, a Research Associate at the National Bureau of Economics Research, a Senior Fellow at the Stanford Institute for Economic Policy Research, a Faculty Member at the Stanford Freeman Spogli Institute, and a Fellow at the Academy of Science and Freedom. His research focuses on the economics of health care around the world with a particular emphasis on the health and well-being of vulnerable populations. Co-Author of the Great Barrington Declaration.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.















